Bookmark and Share
piperidine (CID 8082) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(1)
 
 
Inactive(87)
 
 
Inconclusive(3)
 
 
Unspecified(12)
 
 
Top Targets:
NR LBD PPAR(8)
 
 
NR LBD AR(7)
 
 
NR LBD ER(7)
 
 
 
NR LBD Fxr(4)
 
 
NR LBD VDR(4)
 
 
BioAssay Types:
Confirmatory(62)
 
 
 
Summary(24)
 
 
 
Literature(14)
 
 
 
 
BioActivity Types:
Potency(80)
 
 
 
Kd(2)
 
 
 
Ki(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 103    Data Row: 103   Total Pages: 6   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103178965]
Kd 0.12Ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 2 [AID30389, Type: Literature]
View
2
[SID103178965]
Kd 69Ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 3. [AID30391, Type: Literature]
View
3
[SID103178965]
Ki 54000Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting [AID630741, Type: Literature]Proton-coupled amino acid transporter 1 [gi:51316800]
View
4
[SID103178965]
Compounds was evaluated for their ability to enhance (+/-)-[3H]nicotine binding at a dose range 10 E -9 - 10 E -6 M was reported [AID30528, Type: Literature]
View
5
[SID103178965]
Dissociation constant, pKa of the compound [AID342464, Type: Literature]
View
6
[SID103178965]
Association constant was determined [AID25336, Type: Literature]
View
7
[SID103178965]
Maximum percent of enhancement of binding. [AID30377, Type: Literature]
View
8
[SID103178965]
Maximum percent of inhibition of binding was determined [AID30378, Type: Literature]
View
9
[SID103178965]
Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-9-10e-6 [AID30386, Type: Literature]
View
10
[SID103178965]
pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 2009 [AID781325, Type: Literature]
View
11
[SID103178965]
pKa (acid-base dissociation constant) as determined by Morgenthaler ref: ChemMedChem 2007 [AID781327, Type: Literature]
View
12
[SID103178965]
Dissociation constant, pKa of the compound [AID701844, Type: Literature]
View
13
[SID103178965]
Inhibition of Thromboxane synthetase at 100 uM [AID213129, Type: Literature]Thromboxane-A synthase [gi:254763392]
View
14
[SID144208373]
Potency-Replicate_1 qHTS assay for small molecule agonists of the p53 signaling pathway [AID651631, Type: confirmatory]Cellular tumor antigen p53 [gi:269849759]
View
15
[SID144208373]
Ratio Potency (uM) qHTS assay for small molecule agonists of the p53 signaling pathway: Summary [AID720552, Type: summary]Cellular tumor antigen p53 [gi:269849759]
View
16
[SID144208373]
Potency-Replicate_1 qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 [AID651632, Type: confirmatory]ATPase family AAA domain-containing protein 5 [gi:296439460]
View
17
[SID144208373]
ATAD5 Potency (uM) qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary [AID720516, Type: summary]ATPase family AAA domain-containing protein 5 [gi:296439460]
View
18
[SID144208373]
Potency-Replicate_1 qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway [AID720691, Type: confirmatory]glucocorticoid receptor [Homo sapiens] [gi:311348376]
View
19
[SID144208373]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway [AID720692, Type: confirmatory]glucocorticoid receptor [Homo sapiens] [gi:311348376]
View
20
[SID144208373]
Ratio Potency (uM) qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary [AID720719, Type: summary]glucocorticoid receptor [Homo sapiens] [gi:311348376]
View